In vivo specific reduction of arylsulfatase B enzymatic activity in children with cystic fibrosis
Authors:
- Giovanni Battista FerreroGFGiovanni Battista Ferrero
- Severo PagliardiniSPSevero Pagliardini
- Aleksandar VeljkovicAVAleksandar Veljkovic
- Francesco PortaFPFrancesco Porta
- Cristina BenaCBCristina Bena
- Irene TardivoITIrene Tardivo
- Gabriella RestagnoGRGabriella Restagno
- Margherita Cirillo SilengoMSMargherita Cirillo Silengo
- Elisabetta BignaminiEBElisabetta Bignamini
- 31 May 2008
- journal article
- other
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 94 (1) , 139
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Increased arylsulfatase B activity in cystic fibrosis cells following correction of CFTRClinica Chimica Acta, 2007
- CFTR regulates phagosome acidification in macrophages and alters bactericidal activityNature Cell Biology, 2006
- High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening*The American Journal of Human Genetics, 2006
- Genetic Modifiers of Lung Disease in Cystic FibrosisNew England Journal of Medicine, 2005
- Does Deficiency of Arylsulfatase B Have a Role in Cystic Fibrosis?aChest, 2003